CRISPR/Cas
Swerving the matter of granting genetic scissor patents at the EPO
This autumn, the EPO Boards of Appeal were supposed to issue landmark decisions in the battle for the basic patents on CRISPR/Cas9 technology. But the
...
28 November 2024 by Mathieu Klos